scispace - formally typeset
Y

Ying Yin

Researcher at Academy of Military Medical Sciences

Publications -  27
Citations -  180

Ying Yin is an academic researcher from Academy of Military Medical Sciences. The author has contributed to research in topics: Immunogenicity & Anthrax vaccines. The author has an hindex of 8, co-authored 27 publications receiving 130 citations.

Papers
More filters
Journal ArticleDOI

Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis

TL;DR: It is suggested chimeric HBc particles carrying a neutralizing epitope of PA can induce protective immunity against Bacillus anthracis, and was able to partially protect the immunized guinea pigs against virulent anthrax spores challenge.
Journal ArticleDOI

Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.

TL;DR: This research successfully inserted the 2β2-2β3 loop of PA into the major immunodominant region (MIR) of hepatitis B virus core (HBc) protein, and removed amino acids 79-81 from the HBc MIR of theHBcL2, leading to the full protection of the immunized mice against a lethal dose anthrax toxin challenge.
Journal ArticleDOI

Relative Quantitative Proteomic Analysis of Brucella abortus Reveals Metabolic Adaptation to Multiple Environmental Stresses.

TL;DR: A mass spectrometry-based label-free relative quantitative proteomics approach is utilized to investigate and compare global proteomic changes in B. abortus in response to eight different stress treatments, providing a better understanding of the global metabolic adaptations of B. abortion associated with distinct environmental stresses.
Journal ArticleDOI

Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine.

TL;DR: Investigating the PA domain specificity, affinity, mechanisms of neutralization, and synergistic effects of PA-specific antibodies from a single donor following vaccination with the rPA vaccine provides novel insights into the antibody response elicited by the r PA vaccine and may be useful for PA-based vaccine and immunotherapeutic cocktail design.
Journal ArticleDOI

Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.

TL;DR: A bivalent vaccine where the G proteins of NiV and HeV were fused with the human IgG1 Fc domain and a tetravalent Fc heterodimer fusion protein that contains the G protein domains of four HNVs is constructed, suggesting efficient candidates to prevent HNV infection.